Biology Reference
In-Depth Information
Cortassa S, Aon MA, Marb´n E, Winslow RL, O'Rourke B (2003) An integrated model of cardiac
mitochondrial energy metabolism and calcium dynamics. Biophys J 84:2734-55
Cortassa S, O'Rourke B, Winslow RL, Aon MA (2009) Control and regulation of integrated
mitochondrial function in metabolic and transport networks. Int J Mol Sci 10:1500-13
Dietzen DJ, Davis EJ (1993) Oxidation of pyruvate, malate, citrate, and cytosolic reducing
equivalents by AS-30D hepatoma mitochondria. Arch Biochem Biophys 305:91-102
du Preez FB, Conradie R, Penkler GP, Holm K, van Dooren FL, Snoep JL (2008) A comparative
analysis of kinetic models of erythrocyte glycolysis. J Theor Biol 252:488-96
Eigenbrodt E, Fister P, Reinacher M (1985) New perspectives in carbohydrate metabolism in
tumor cells. In: Reitner R (ed) Regulation of carbohydrate metabolism. CRC, Boca Raton, FL
El-Bacha T, de Freitas MS, Sola-Penna M (2003) Cellular distribution of phosphofructokinase
activity and implications to metabolic regulation in human breast cancer. Mol Genet Metab
79:294-9
Evans A, Bates V, Troy H, Hewitt S, Holbeck S, Chung YL, Phillips R, Stubbs M, Griffiths J,
Airley R (2008) GLUT1 as a therapeutic target: increased chemoresistance and HIF-1-inde-
pendent link with cell turnover is revealed through compare analysis and metabolomic studies.
Cancer Chemother Pharmacol 61:377-93
Fanciulli M, Bruno T, Giovannelli A, Gentile FP, Di Padova M, Rubiu O, Floridi A (2000) Energy
metabolism of human LoVo colon carcinoma cells: correlation to drug resistance and influence
of lonidamine. Clin Cancer Res 6:1590-97
Fell D (1997) Understanding the control of metabolism. Plenum, London
Funasaka T, Hu H, Hogan V, Raz A (2007) Down-regulation of phosphoglucose isomerase/
autocrine motility factor expression sensitizes human fibrosarcoma cells to oxidative stress
leading to cellular senescence. J Biol Chem 282:36362-69
Gaitonde MK, Murray E, Cunningham VJ (1989) Effect of 6-phosphogluconate on
phosphoglucose isomerase in rat brain in vitro and in vivo. J Neurochem 52:1348-52
Goldberg MS, Sharp PA (2012) Pyruvate kinase M2-specific siRNA induces apoptosis and tumor
regression. J Exp Med 209:217-24
Hellerstein MK (2008) A critique of the molecular target-based drug discovery paradigm based on
principles of metabolic control: advantages of pathway-based discovery. Metab Eng 10:1-9
Hoops S, Sahle S, Gauges R, Lee C, Pahle J, Simus N, Singhal M, Xu L, Mendes P, Kummer U
(2006) COPASI—a COmplex PAthway SImulator. Bioinformatics 22:3067-74
Hornberg JJ, Binder B, Bruggeman FJ, Schoeberl B, Heinrich R, Westerhoff HV (2005) Control of
MAPK signalling: from complexity to what really matters. Oncogene 24:5533-42
Hornberg JJ, Bruggeman FJ, Westerhoff HV, Lankelma J (2006) Cancer: a systems biology
disease. Biosystems 83:81-90
Hornberg JJ, Bruggeman FJ, Bakker BM, Westerhoff HV (2007) Metabolic control analysis to
identify optimal drug targets. Prog Drug Res 64:173-89
H¨bner K, Sahle S, Kummer U (2011) Applications and trends in systems biology in biochemistry.
FEBS J 278:2767-857
Khayat ZA, McCall AL, Klip A (1998) Unique mechanism of GLUT3 glucose transporter
regulation by prolonged energy demand: increased protein half-life. Biochem J 333:713-18
Kim JE, Ahn BC, Hwang MH, Jeon YH, Jeong SY, Lee SW, Lee J (2011) Combined RNA
interference of hexokinase II and (131)I-sodium iodide symporter gene therapy for anaplastic
thyroid carcinoma. J Nucl Med 52:1756-63
Kohn MC, Achs MJ, Garfinkel D (1979) Computer simulation of metabolism in pyruvate-perfused
rat heart. II. Krebs cycle. Am J Physiol 237:R159-R166
Kolodkin A, Boogerd FC, Plant N et al (2012) Emergence of the silicon human and network
targeting drugs. Eur J Pharm Sci 46:190-7
Kumagai S, Narasaki R, Hasumi K (2008) Glucose-dependent active ATP depletion by koningic
acid kills high-glycolytic cells. Biochem Biophys Res Commun 365:362-8
Lee KA, Roth RA, LaPres JJ (2007) Hypoxia, drug therapy and toxicity. Pharmacol Ther
113:229-46
Search WWH ::
Custom Search